Position in VRTX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$2,502,029
+$288,531 QoQ
Shares Held
5,037
+1.6% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.72%
of 13F equity value
Holder Rank
#615
of 1,735 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Future Fund LLC holds $27,055,231 across 6 Biotechnology names. VRTX ranks #4 (9.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HALO |
Halozyme Therapeutics, Inc.
|
142,007 | $11,114,887 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
|
71,362 | $5,658,292 | |
| 3 | LGND |
Ligand Pharmaceuticals Inc
|
14,704 | $4,647,787 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
5,037 | $2,502,029 | |
| 5 | ADMA |
Adma Biologics, Inc.
|
248,524 | $2,080,145 | |
| 6 | ARGX |
Argenx SE
|
1,134 | $1,052,091 |
All Filings in VRTX
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,502,029 | 5,037 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $2,213,498 | 4,957 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $2,177,488 | 4,803 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $2,031,436 | 5,187 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,782,135 | 4,003 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $2,108,482 | 4,349 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $826,340 | 2,052 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $791,566 | 1,702 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $1,023,684 | 2,184 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $270,034 | 646 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $390,614 | 960 | Shares | Sole | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||